Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of the radiation therapy oncology group trial (RTOG) 90-01

Concurrent Chemotherapy ◽

Oncology Group ◽

Pelvic Irradiation ◽

Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of the radiation therapy oncology group trial (RTOG) 90-01

The Women s Oncology Review ◽

10.1080/1473340410001732451 ◽

2004 ◽

Vol 4 (2) ◽

pp. 119-120

Keyword(s):

Cervical Cancer ◽

Radiation Therapy ◽

High Risk ◽

Concurrent Chemotherapy ◽

Oncology Group ◽

Pelvic Irradiation ◽

Clinical Outcome Analysis in “High-Risk” Versus “Low-Risk” Patients Eligible For National Surgical Adjuvant Breast and Bowel B-39/Radiation Therapy Oncology Group 0413 Trial: Five-Year Results

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2007.12.005 ◽

2008 ◽

Vol 70 (4) ◽

pp. 970-973 ◽

Cited By ~ 47

Author(s):

Rakesh R. Patel ◽

Michael E. Christensen ◽

C. Wesley Hodge ◽

Jarrod B. Adkison ◽

Rupak K. Das

Keyword(s):

Radiation Therapy ◽

High Risk ◽

Clinical Outcome ◽

Low Risk ◽

Outcome Analysis ◽

Oncology Group ◽

National Surgical Adjuvant Breast ◽

Risk Patients

Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical–pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial

Gynecologic Oncology ◽

10.1016/j.ygyno.2004.11.007 ◽

2005 ◽

Vol 96 (3) ◽

pp. 721-728 ◽

Cited By ~ 120

Author(s):

Bradley J. Monk ◽

Jianmin Wang ◽

Samuel Im ◽

Richard J. Stock ◽

William A. Peters ◽

...

Keyword(s):

Radiation Therapy ◽

Radical Hysterectomy ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Southwest Oncology Group ◽

Pathologic Analysis ◽

Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: Results of a prospective randomized trial conducted by the radiation therapy oncology group

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/0360-3016(91)90681-s ◽

1991 ◽

Vol 21 (3) ◽

pp. 637-643 ◽

Cited By ~ 124

Author(s):

A.H. Russell ◽

T.E. Pajak ◽

H.M. Selim ◽

J.C. Paradelo ◽

K. Murray ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

High Risk ◽

Randomized Trial ◽

Cancer Patients ◽

Cranial Irradiation ◽

Prophylactic Cranial Irradiation ◽

Oncology Group ◽

Lung Cancer Patients

Radiation Therapy Oncology Group Protocol 02-29: A Phase II Trial of Neoadjuvant Therapy With Concurrent Chemotherapy and Full-Dose Radiation Therapy Followed by Surgical Resection and Consolidative Therapy for Locally Advanced Non-small Cell Carcinoma of the Lung

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2011.11.069 ◽

2012 ◽

Vol 84 (2) ◽

pp. 456-463 ◽

Cited By ~ 58

Author(s):

Mohan Suntharalingam ◽

Rebecca Paulus ◽

Martin J. Edelman ◽

Mark Krasna ◽

Whitney Burrows ◽

...

Keyword(s):

Radiation Therapy ◽

Cell Carcinoma ◽

Neoadjuvant Therapy ◽

Phase Ii Trial ◽

Locally Advanced ◽

Concurrent Chemotherapy ◽

Small Cell ◽

Oncology Group ◽

Dose Radiation

Randomized Trial of Amifostine in Locally Advanced Non-Small-Cell Lung Cancer Patients Receiving Chemotherapy and Hyperfractionated Radiation: Radiation Therapy Oncology Group Trial 98-01

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70146-5 ◽

2006 ◽

Vol 2006 ◽

pp. 207-208

Author(s):

N.H. Hanna

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Cancer Patients ◽

Locally Advanced ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Cytoprotection/radioprotection with amifostine: potential role in cervical cancer and early findings in the radiation therapy oncology group C-0116 trial

Seminars in Oncology ◽

10.1053/j.seminoncol.2003.11.019 ◽

2003 ◽

Vol 30 ◽

pp. 68-71 ◽

Cited By ~ 9

Author(s):

William Small

Keyword(s):

Cervical Cancer ◽

Radiation Therapy ◽

Potential Role ◽

Oncology Group

Radiation Therapy Oncology Group 0521: A Phase III Randomized Trial of Androgen Suppression and Radiation Therapy Versus Androgen Suppression and Radiation Therapy Followed by Docetaxel/Prednisone for Localized, High-Risk Prostate Cancer

Clinical Genitourinary Cancer ◽

10.3816/cgc.2005.n.035 ◽

2005 ◽

Vol 4 (3) ◽

pp. 212-214 ◽

Cited By ~ 15

Author(s):

Asmita R. Patel ◽

Howard M. Sandler ◽

Kenneth J. Pienta

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Randomized Trial ◽

Phase Iii ◽

Oncology Group ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer ◽

Androgen Suppression

Phase II Radiation therapy oncology group trial of weekly paclitaxel and conventional external beam radiation therapy for supratentorial glioblastoma multiforme

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(01)01597-8 ◽

2001 ◽

Vol 51 (1) ◽

pp. 113-119 ◽

Cited By ~ 27

Author(s):

Corey J. Langer ◽

James Ruffer ◽

Harker Rhodes ◽

Rebecca Paulus ◽

Kevin Murray ◽

...

Keyword(s):

Radiation Therapy ◽

Glioblastoma Multiforme ◽

Phase Ii ◽

External Beam Radiation Therapy ◽

External Beam Radiation ◽

External Beam ◽

Oncology Group ◽

Beam Radiation ◽

P-53 Phase I dose-escalation study of thoracic irradiation with concurrent chemotherapy for patients with limited small cell lung cancer (LSCLC). Radiation therapy oncology group (RTOG) protocol 9712

Lung Cancer ◽

10.1016/s0169-5002(03)92022-8 ◽

2003 ◽

Vol 41 ◽

pp. S104

Author(s):

Ritsuko Komaki ◽

Suzanne Swann ◽

David Ettinger ◽

Bonnie Glisson ◽

Alan Sandler ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Concurrent Chemotherapy ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

Dose Escalation Study ◽

Thoracic Irradiation ◽

P 53